352 views
Photo from Tracxn

Late‑stage deals dominate startup funding in April to May

Seed-stage companies secured $52.2m as total investments reached $214m.

Late-stage deals were the dominant source of startup funding in Singapore, accounting for $157.8m, or 73.9%, of the $214m raised between 1 April and 31 May, according to Tracxn.

Seed-stage startups attracted $52.2m, representing 24.4% of total funding, whilst early-stage companies raised $3.7m for the period.

Amongst completed quarters, late-stage funding reached $2.4b in the first quarter (Q1) of 2026 and $460m in Q2 2025.

Seed-stage funding stood at $105.8m in Q1 2026 and $48.5m in Q2 2025, whilst early-stage funding totalled $459.6m and $218.1m, respectively.

The latest funding activity was led by Silicon Box’s $150m round, followed by Simple Chain at $15m, Biobot Surgical at $7.8m, Brano Therapeutics at $6.8m, and Atlas at $6m.

Join Singapore Business Review community

Follow the link for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.